Heidi Vaughan, MD | |
1215 Lee St # 800904, Charlottesville, VA 22908-0816 | |
(434) 982-1018 | |
(434) 924-9492 |
Full Name | Heidi Vaughan |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1215 Lee St # 800904, Charlottesville, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033869474 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 0101280280 (Virginia) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Heidi Vaughan, MD 1215 Lee St Box 800904, Charlottesville, VA 22908-0816 Ph: (434) 982-1018 | Heidi Vaughan, MD 1215 Lee St # 800904, Charlottesville, VA 22908-0816 Ph: (434) 982-1018 |
News Archive
Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.
Hubris is the greatest danger in wealthy countries -; a sort of smug assumption that advanced technologies and emergency-preparedness plans guarantee that Ebola and other germs will not spread. It was hubris that left Toronto's top hospitals battling SARS in 2003, long after the virus was conquered in poorer Vietnam. It was hubris that led the World Health Assembly in 2013 to cut the WHO's outbreak-response budget in favor of more programs to treat cancer and heart disease.
In recognition of November as National Diabetes Month, the American College of Occupational and Environmental Medicine (ACOEM) is providing tools and resources to help employers identify and respond to the impact of diabetes on worker health and productivity.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
With the holiday season upon us, children are busy making their wish lists and checking them twice. But, parents may need to check them yet again to ensure toy safety. According to the U.S. Consumer Product Safety Commission, more than 250,000 toy-related injuries are treated in emergency rooms each year.
› Verified 7 days ago